Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acer Therapeutics Inc. (PFTR.OB) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acer Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1069308.
Total stock buying since 2014: $11,318,289.
Total stock sales since 2014: $8,202.
Total stock option exercises since 2014: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2022 | 1,229,508 | $1,499,998 | 0 | $0 | 0 | $0 |
2021 | 10,000 | $20,621 | 0 | $0 | 0 | $0 |
2020 | 223,570 | $782,494 | 0 | $0 | 0 | $0 |
2019 | 5,000 | $18,580 | 0 | $0 | 0 | $0 |
2018 | 275,000 | $4,950,000 | 0 | $0 | 0 | $0 |
2017 | 335,333 | $4,023,996 | 0 | $0 | 0 | $0 |
2016 | 0 | $0 | 14,914 | $8,202 | 0 | $0 |
2015 | 0 | $0 | 0 | $0 | 682,525 | $0 |
2014 | 20,000 | $22,600 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2022-11 | 1,229,508 | $1,499,998 | 0 | $0 | 0 | $0 |
2021-12 | 10,000 | $20,621 | 0 | $0 | 0 | $0 |
2020-07 | 223,570 | $782,494 | 0 | $0 | 0 | $0 |
2019-07 | 5,000 | $18,580 | 0 | $0 | 0 | $0 |
2018-08 | 275,000 | $4,950,000 | 0 | $0 | 0 | $0 |
2017-12 | 335,333 | $4,023,996 | 0 | $0 | 0 | $0 |
2016-11 | 0 | $0 | 14,914 | $8,202 | 0 | $0 |
2015-04 | 0 | $0 | 0 | $0 | 682,525 | $0 |
2014-09 | 20,000 | $22,600 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-11-29 | Schelling Chris (President & CEO) | Buy | 819,672 | 1.22 | 999,999 |
2022-11-29 | Aselage Steve (Director) | Buy | 409,836 | 1.22 | 499,999 |
2021-12-10 | Aselage Steve (Director) | Buy | 7,984 | 2.04 | 16,287 |
2021-12-09 | Aselage Steve (Director) | Buy | 2,016 | 2.15 | 4,334 |
2020-07-24 | Schelling Chris (President & CEO) | Buy | 142,857 | 3.50 | 499,999 |
2020-07-24 | Joseph Donald (Chief Legal Officer and Secy) | Buy | 14,285 | 3.50 | 49,997 |
2020-07-24 | Dunn John Michael (Director) | Buy | 21,428 | 3.50 | 74,998 |
2020-07-24 | Aselage Steve (Director) | Buy | 45,000 | 3.50 | 157,500 |
2019-07-03 | Aselage Steve (Director) | Buy | 5,000 | 3.72 | 18,580 |
2018-08-01 | Leatt Gary (10% Owner) | Buy | 275,000 | 18.00 | 4,950,000 |
2017-12-14 | Aselage Steve (Director) | Buy | 2,000 | 12.00 | 24,000 |
2017-12-12 | Leatt Gary (10% Owner) | Buy | 333,333 | 12.00 | 3,999,996 |
2016-11-18 | Barabe Timothy C (Director) | Sale | 14,914 | .55 | 8,202 |
2015-04-08 | Radhakrishnan Karthik (Chief Financial Officer) | Option Ex | 50,000 | .00 | 0 |
2015-04-08 | Maderis Gail J (Director) | Option Ex | 8,242 | .00 | 0 |
2015-04-08 | Warma Neil K (President and CEO) | Option Ex | 37,247 | .00 | 0 |
2015-04-08 | Richman Michael (Director) | Option Ex | 8,242 | .00 | 0 |
2015-04-08 | Seaman Scott B (Director) | Option Ex | 562,794 | .00 | 0 |
2015-04-08 | Barabe Timothy C (Director) | Option Ex | 16,000 | .00 | 0 |
2014-09-17 | Barabe Timothy C | Buy | 10,000 | 1.15 | 11,500 |
2014-09-16 | Warma Neil K (President & CEO) | Buy | 10,000 | 1.11 | 11,100 |
Insider trading activities including stock purchases, stock sales, and option exercises of PFTR.OB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acer Therapeutics Inc. (symbol PFTR.OB, CIK number 1069308) see the Securities and Exchange Commission (SEC) website.